Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$35.55 - $43.57 $723,584 - $886,823
20,354 Added 4.52%
470,882 $20.5 Million
Q3 2023

Nov 14, 2023

SELL
$39.13 - $47.24 $648,266 - $782,625
-16,567 Reduced 3.55%
450,528 $18.2 Million
Q2 2023

Aug 14, 2023

BUY
$43.93 - $46.76 $591,781 - $629,903
13,471 Added 2.97%
467,095 $21 Million
Q1 2023

May 15, 2023

BUY
$45.29 - $50.76 $3.55 Million - $3.98 Million
78,391 Added 20.89%
453,624 $20.8 Million
Q4 2022

Feb 14, 2023

BUY
$41.91 - $50.48 $12.9 Million - $15.6 Million
308,425 Added 461.66%
375,233 $18.7 Million
Q3 2022

Nov 14, 2022

BUY
$40.9 - $50.42 $274,234 - $338,066
6,705 Added 11.16%
66,808 $2.76 Million
Q2 2022

Aug 09, 2022

BUY
$42.98 - $49.77 $2.58 Million - $2.99 Million
60,064 Added 154010.27%
60,103 $2.84 Million
Q2 2021

Aug 12, 2021

BUY
$46.28 - $52.75 $1,804 - $2,057
39 New
39 $1,000
Q3 2020

Nov 13, 2020

SELL
$42.51 - $52.42 $29,799 - $36,746
-701 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$39.49 - $44.36 $15,796 - $17,744
400 Added 132.89%
701 $30,000
Q4 2019

Feb 13, 2020

SELL
$25.41 - $43.1 $55.4 Million - $94 Million
-2,180,000 Reduced 99.99%
301 $9,000
Q1 2019

May 13, 2019

BUY
$33.78 - $40.68 $25 Million - $30.1 Million
741,000 Added 51.48%
2,180,301 $88.7 Million
Q4 2018

Feb 13, 2019

SELL
$32.65 - $37.95 $1.49 Million - $1.73 Million
-45,500 Reduced 3.06%
1,439,301 $49.6 Million
Q3 2018

Nov 13, 2018

BUY
$35.99 - $39.39 $10,832 - $11,856
301 Added 0.02%
1,484,801 $56.2 Million
Q2 2018

Aug 13, 2018

BUY
$31.23 - $37.47 $46.4 Million - $55.6 Million
1,484,500 New
1,484,500 $53.7 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.24B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.